<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02016352</url>
  </required_header>
  <id_info>
    <org_study_id>10 045 08</org_study_id>
    <secondary_id>2011-A01091-40</secondary_id>
    <nct_id>NCT02016352</nct_id>
  </id_info>
  <brief_title>Cerebrospinal Fluid Proteome in Hydrocephalus</brief_title>
  <acronym>PROLIPHYC</acronym>
  <official_title>Cerebrospinal Fluid Proteome in Hydrocephalus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      PROLIPHYC is a collaborative prospective study that aims at discovering deep cerebrospinal
      fluid (CSF) proteome with a new clinically-compatible proteomics strategy, in a cohort of 100
      patients suspected of neurodegenerative diseases and/or normal pressure hydrocephalus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      CSF proteome is the real time protein content that may reveal useful biomarkers for diagnosis
      and therapeutic decision-making. But the low protein concentration in CSF and the low volumes
      typically obtained after lumbar puncture precludes the conventional use of proteomic
      analysis. We miniaturized the method to be compatible with low-volume samples by combination
      of nanoLC-MS/MS analysis and combinatorial peptide ligand library technology to reduce the
      dynamic range of protein concentration in CSF and unmask previously undetected proteins. We
      demonstrated that this deep proteomic analysis allows profiling the CSF proteome with a
      reasonable depth, in short analytical times and good accuracy. We settled a
      clinically-compatible proteomics strategy targeting the deep CSF proteome discovery.

      The PROLIPHYC study is a prospective study that aims at analysing CSF proteome with our new
      strategy in a cohort of patients suspected of normal pressure hydrocephalus and/or related
      neurodegenerative diseases. The PROLIPHYC project combines detailed clinical and
      neuropsychological evaluation, gait analysis, MRI brain imaging, lumbar CSF dynamics and deep
      proteome. We hypothesize in the PROLIPHYC study that a specific cluster of polypeptides can
      be associated with Alzheimer disease, vascular dementia and normal pressure hydrocephalus
      profiles. Validating this hypothesis might be a significant step towards a proteomic lexicon
      of aging brain, neurodegenerative diseases and dementia.

      Neurosciences department and Alzheimer disease centre from the Toulouse University Hospital
      are both involved in this project. The deep proteomic study is performed in Toulouse by the
      Institute of Pharmacology and Structural Biology with the academic support of the Institute
      of Mathematics of Toulouse.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CSF proteome measure</measure>
    <time_frame>48 hours</time_frame>
    <description>CSF extraction (3 ml)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>correlation between CSF proteome and gait analysis</measure>
    <time_frame>72 hours</time_frame>
    <description>compare results from CSF proteome and gait analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>correlation between CSF proteome and MRI brain imaging</measure>
    <time_frame>72 hours</time_frame>
    <description>compare results from CSF proteome and brain imaging</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Normal Pressure Hydrocephalus</condition>
  <arm_group>
    <arm_group_label>patient</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patient CSF extraction with hydrocephalus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>witness</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patient without hydrocephalus but with peridural catheter for anesthetic. Witness CSF extraction has realized on catheter.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>patient CSF extraction with hydrocephalus</intervention_name>
    <description>CSF extraction</description>
    <arm_group_label>patient</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>witness CSF extraction</intervention_name>
    <description>CSF extraction from patient not suffering from hydrocephalus</description>
    <arm_group_label>witness</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gait problems, cognitive decline, urinary incontinence and enlarged ventricles on
             imaging

        Exclusion Criteria:

          -  Psychiatric disorders

          -  Lumbar punction contraindication

          -  RMI contraindication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric SCHMIDT, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Bech-Azeddine R, HÃ¸gh P, Juhler M, Gjerris F, Waldemar G. Idiopathic normal-pressure hydrocephalus: clinical comorbidity correlated with cerebral biopsy findings and outcome of cerebrospinal fluid shunting. J Neurol Neurosurg Psychiatry. 2007 Feb;78(2):157-61. Epub 2006 Sep 29.</citation>
    <PMID>17012342</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2013</study_first_submitted>
  <study_first_submitted_qc>December 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 20, 2013</study_first_posted>
  <last_update_submitted>November 24, 2017</last_update_submitted>
  <last_update_submitted_qc>November 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hydrocephalus</keyword>
  <keyword>proteomic</keyword>
  <keyword>cerebrospinal fluid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocephalus</mesh_term>
    <mesh_term>Hydrocephalus, Normal Pressure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

